Ambrosi, Lara
Khan, Shaheer
Carvajal, Richard D.
Yang, Jessica
Article History
First Online: 6 November 2019
Compliance with Ethical Standards
:
: Lara Ambrosi declares that she has no conflict of interest.Shaheer Khan declares that he has no conflict of interest.Richard D. Carvajal is supported by research funding (paid to his institution) by Bristol-Myers Squibb, Immunocore, Incyte Corporation, Merck, Roche/Genentech, Amgen, Novartis, Pfizer, AstraZeneca, Bellicum Pharmaceuticals, Plexxikon, Mirati Therapeutics, MacroGenics, Corvus Pharmaceuticals, Bayer, Eli Lilly, and Astellas; has received compensation from Bristol-Myers Squibb, Castle Biosciences, Compugen, Foundation Medicine, Immunocore, I-Mab Biopharma, Incyte Corporation, Merck, Roche/Genentech, PureTech Health, Sanofi Genzyme, and Sorrento Therapeutics for service as a consultant; and has received compensation from Aura Biosciences, Chimeron Bio, and Rgenix for participation on clinical/scientific advisory boards.Jessica Yang declares that she has no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.